Millie Hughes-Fulford

Millie Hughes-Fulford

Auto-generated profile, based on publicly available information

Millie Hughes-Fulford

Department of Medicine, Veterans Affairs Medical Center, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Tissue Engineering Part A
Verified
Journal Article
Closed access
TCTammy T. Chang
Tammy T. Chang
MHMillie Hughes-Fulford
Millie Hughes-Fulford
Understanding cell biology of three-dimensional (3D) biological structures is important for more complete appreciation of in vivo tissue function and advancing ex vivo organ engineering efforts. To elucidate how 3D structure may affect hepatocyte cellular responses, we compared global gene expression of human liver hepatocellular carcinoma cell line (HepG2) cells cultured as monolayers on tissue culture dishes (TCDs) or as spheroids within rotating wall vessel (RWV) bioreactors. HepG2 cells grown in RWVs form spheroids up to 100 μm in diameter within 72 h and up to 1 mm with long-term culture. The actin cytoskeleton in monolayer cells show stress fiber formation while spheroids have cortical actin organization. Global gene expression analysis demonstrates upregulation of structural genes such as extracellular matrix, cytoskeletal, and adhesion molecules in monolayers, whereas RWV spheroids show upregulation of metabolic and synthetic genes, suggesting functional differences. Indeed, liver-specific functions of cytochrome P450 activity and albumin production are higher in the spheroids. Enhanced liver functions require maintenance of 3D structure and environment, because transfer of spheroids to a TCD results in spheroid disintegration and subsequent loss of function. These findings illustrate the importance of physical environment on cellular organization and its effects on hepatocyte processes.

1 April 1996 in Experimental Cell Research
Verified
Journal Article
Closed access
MHM. Hughes-Fulford
M. Hughes-Fulford
MLM.L. Lewis
M.L. Lewis

1 April 1997 in British Journal of Cancer
Verified
Journal Article
Open access
RTRr Tjandrawinata
Rr Tjandrawinata
RDR Dahiya
R Dahiya
MHM Hughes-Fulford
M Hughes-Fulford
Prostaglandins are synthesized from arachidonic acid by the enzyme cyclo-oxygenase. There are two isoforms of cyclooxygenases: COX-1 (a constitutive form) and COX-2 (an inducible form). COX-2 has recently been categorized as an immediate-early gene and is associated with cellular growth and differentiation. The purpose of this study was to investigate the effects of exogenous dimethylprostaglandin E2 (dmPGE2) on prostate cancer cell growth. Results of these experiments demonstrate that administration of dmPGE2 to growing PC-3 cells significantly increased cellular proliferation (as measured by the cell number), total DNA content and endogenous PGE2 concentration. DmPGE2 also increased the steady-state mRNA levels of its own inducible synthesizing enzyme, COX-2, as well as cellular growth to levels similar to those seen with fetal calf serum and phorbol ester. The same results were observed in other human cancer cell types, such as the androgen-dependent LNCaP cells, breast cancer MDA-MB-134 cells and human colorectal carcinoma DiFi cells. In PC-3 cells, the dmPGE2 regulation of the COX-2 mRNA levels was both time dependent, with maximum stimulation seen 2 h after addition, and dose dependent on dmPGE2 concentration, with maximum stimulation seen at 5 microg ml(-1). The non-steroidal anti-inflammatory drug flurbiprofen (5 microM), in the presence of exogenous dmPGE2, inhibited the up-regulation of COX-2 mRNA and PC-3 cell growth. Taken together, these data suggest that PGE2 has a specific role in the maintenance of human cancer cell growth and that the activation of COX-2 expression depends primarily upon newly synthesized PGE2, perhaps resulting from changes in local cellular PGE2 concentrations.

8 December 2000 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
YCYunfei Chen
Yunfei Chen
MHMillie Hughes-Fulford
Millie Hughes-Fulford
The low‐density lipoprotein receptor (LDLR) pathway provides cells with essential fatty acids for prostaglandin E2 (PGE2) synthesis. Regulation of LDLR expression by LDL was compared between the human normal and cancer prostate cells using semi‐quantitative RT‐PCR and LDL uptake assays. LDLR mRNA expression and LDL uptake by LDLR were down‐regulated in the presence of exogenous LDL or whole serum in the normal prostate cells, but not in the prostate cancer cells. Addition of exogenous cholesterol down‐regulated both LDLR and a potent regulator of the ldlr promoter, sterol regulatory element binding protein 2 (SREBP2), in normal cells but not in cancer cells. PGE2 synthesis in prostate cancer cells was significantly increased in response to LDL. Our study suggests that over‐production of LDLR is an important mechanism in cancer cells for obtaining more essential fatty acids through LDLR endocytosis, allowing increased synthesis of prostaglandins, which subsequently stimulate cell growth. The data also suggest that the sterol regulatory element and SREBP2 play a role in the loss of sterol feedback regulation in cancer cells. Int. J. Cancer 91:41–45, 2001.

6 October 2005 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
JBJ. B. Boonyaratanakornkit
J. B. Boonyaratanakornkit
ACA. Cogoli
A. Cogoli
CLC.‐F. Li
C.‐F. Li
TST. Schopper
T. Schopper
PPP. Pippia
P. Pippia
MHM. Hughes‐Fulford
M. Hughes‐Fulford

1 October 2003 in Advances In Space Research
Verified
Journal Article
Closed access
MHM. Hughes-Fulford
M. Hughes-Fulford